Casinvent Pharma
Brno
About Casinvent Pharma
Casinvent Pharma provides pharmaceutical solutions for the treatment of selected malignancies. It is based on the use of proprietary selective inhibitors of enzymes from the CK1 family for leukemia cell migration into lymphoid organs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.0M
- Last round: Series Unknown (Jul 2025)
- Website: casinvent.com
- Phone: +42- 072-899-5850
Industries & Categories
Medical, Oncology, Pharmaceutical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/casinvent-pharma-67195 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.